Determining the Role of Combination CDK4/6i + AI Therapy in HR+ mBC: The SONIA Trial

Video

Shared insight from the Oncology Brothers and Stephanie Graff, MD, FACP, on the role of CDK4/6 inhibition in combination with aromatase inhibitor therapy following data from the SONIA trial in HR+ metastatic breast cancer.

Recent Videos
3 KOLs are featured in this series.
Related Content